MDWD MediWound Ltd.

NASDAQ
$12.90

MediWound Ltd. (MDWD) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $0.63 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.4% since its last earnings release on November 12, 2026.

MediWound Beat Consensus Estimates, Provides Guidance Update
Thursday, November 12, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.63)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.95

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About MediWound Ltd.

MediWound Ltd. is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.